Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avactis Biosciences
Freehold, New Jersey, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Avactis Biosciences supports the development, manufacturing, and standardization of next-generation CAR-T and CAR-NK immunotherapies, with CD19-targeted therapy in Phase 1 trials, and other programs in preclinical or translational stages. Over 300 cases of CAR-T therapy have been completed in collaboration with LuDaopei Hospital, focusing on hematologic cancers. Exosome-based regenerative programs (ACTEX) are at the commercial and preclinical development stage, targeting wound healing and fibrosis.
- Therapeutic areas
- GastroenterologyOncologyEndocrinologyRare Diseases
- Modalities
- CAR-T cell therapyCAR-NK cell therapyExosome-based therapy
- Industry
- Biotech
02
Partnerships
Arbele Limited (joint venture for multi-targeted CAR platforms)LuDaopei Hospital (clinical affiliate and bio-manufacturing collaboration)Weill Cornell Medicine (exosome R&D)
Beyond the preview
Go deeper on Avactis Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avactis Biosciences.